Journal profile · Medicine-Hematology
Thrombosis Journal
ISSN 1477-9560 · BioMed Central · ENGLAND · Founded 2003
Thrombosis Journal: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.67; fully open access; APC about USD 3,090; median 118 days to acceptance (105 articles, last 24 months); 133 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Thrombosis Journal is published by BioMed Central and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Venous Thromboembolism Diagnosis and Management, Blood Coagulation and Thrombosis Mechanisms and Atrial Fibrillation Management and Outcomes, together about 45.9% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
Thrombosis Journal is an open-access journal that publishes original articles on aspects of clinical and basic research, new methodology, case reports and reviews in the areas of thrombosis. Topics of particular interest include the diagnosis of arterial and venous thrombosis, new antithrombotic treatments, new developments in the understanding, diagnosis and treatments of atherosclerotic vessel disease, relations between haemostasis and vascular disease, hypertension, diabetes, immunology and obesity.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Hematology
Editor-in-chief Stefano BarcoPublisher website
Editorial board by country: 10 in mainland China (about 13%); most named United States 13, Mainland China 10, United Kingdom 7, Japan 6, Germany 5 (79 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Venous Thromboembolism Diagnosis and ManagementMedicine22.4%
- Blood Coagulation and Thrombosis MechanismsMedicine12.9%
- Atrial Fibrillation Management and OutcomesMedicine10.6%
- Heparin-Induced Thrombocytopenia and ThrombosisMedicine7%
- Platelet Disorders and TreatmentsMedicine5.9%
- Blood properties and coagulationMedicine4.5%
- Antiplatelet Therapy and Cardiovascular DiseasesMedicine4%
- Trauma, Hemostasis, Coagulopathy, ResuscitationMedicine3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.67LetPub ·
- Impact factor (publisher) 2025
- 2.7Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.5Publisher website ·
- CiteScore 2026-06
- 3.8LetPub ·
- SJR 2026-06
- 0.74LetPub ·
- SNIP 2026-06
- 0.94LetPub ·
- h-index
- 63OpenAlex ·
- i10-index
- 491OpenAlex ·
- 2-year mean citedness
- 2.5OpenAlex ·
- Self-citation rate
- 3.7%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 131LetPub ·
- Downloads per year (publisher) 2025
- 783,200Publisher website ·
Articles by year OpenAlex count · 1,111 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 105 | 105 | 21 |
| 2025 | 133 | 133 | 279 |
| 2024 | 112 | 112 | 574 |
| 2023 | 124 | 124 | 1,121 |
| 2022 | 82 | 82 | 889 |
| 2021 | 106 | 106 | 1,729 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
118 daysMedian, submission to acceptance · P25–P75 77 days – 183 days
- Acceptance to online
- median 13 days (105 articles)
- Submission to online
- median 139 days
- Sample
- 105 articles with submission and acceptance dates (263 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Submission to first decision
- 8 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,590 / USD 3,090 / GBP 2,190 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 3,090 / EUR 2,590 / GBP 2,190 | — | — | |
| LetPub | GBP 2,090 / USD 2,990 / EUR 2,490 | Yes | — |
Other charges and waivers (author guidelines)
- Other fees
- Charged; see the journal's website for the amount
- Page charges
- Charged; see the journal's website for the amount
- Submission fee
- Charged; see the journal's website for the amount
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteExcerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- ENGLAND
- Language
- English
- Founded
- 2003
- ISSN
- 1477-9560
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Thrombosis Journal
What CAS zone is Thrombosis Journal in?
In the 2025 upgraded edition of the CAS Journal Ranking, Thrombosis Journal is in Zone 3 of Medicine, and in Zone 3 of the minor category Hematology / Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Thrombosis Journal?
The latest impact factor listed by LetPub is 2.67; CiteScore 3.8, h-index 63.
How long does peer review take at Thrombosis Journal?
Based on the dates recorded on 105 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 118 days (interquartile range 77–183 days); authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Thrombosis Journal based?
Of the 79 board members whose country the journal's board page names, 10 (about 13%) are in mainland China; the countries named most often are United States (13), Mainland China (10) and United Kingdom (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Thrombosis Journal?
According to LetPub and DOAJ records, Thrombosis Journal is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Embase, CAS and Current Contents; that list has not been checked against each database.
Is Thrombosis Journal open access, and what is the APC?
Thrombosis Journal is a fully open-access journal. APC about USD 3,090.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .